percellvac
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02709616)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- percellvac
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02808364 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2016 | Beijing Tricision Biotherapeutics Inc, Guangzhou Medical University, Guangzhou Trinomab Biotech Co., Ltd., Jinan University |
| NCT02808416 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2016 | Beijing Tricision Biotherapeutics Inc, Guangzhou Medical University, Guangzhou Trinomab Biotech Co., Ltd., Jinan University |
| NCT02709616 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2016 | Beijing Tricision Biotherapeutics Inc, Guangzhou Medical University, Guangzhou Trinomab Biotech Co., Ltd., Jinan University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Tricision Biotherapeutics Inc | Government | 3 | 0 | 1 | 2016 |
| Guangzhou Medical University | Academic/Hospital | 3 | 3 | 1 | 2016 |
| Guangzhou Trinomab Biotech Co., Ltd. | Government | 3 | 0 | 1 | 2016 |
| Jinan University | Academic/Hospital | 3 | 0 | 1 | 2016 |
4 organizations
Page 1 / 1